Literature DB >> 3956827

The effect of ten years of regionalized perinatal health care in Iowa, U.S.A.

H A Hein, L F Burmeister.   

Abstract

In 1973, Iowa, a rural, midwestern state in the U.S.A., established a Statewide Perinatal Care Program. A major objective was to develop and maintain a regionalized system of care. Such a system has been developed but differed from traditional systems by using regional level II centers. Iowa's low population density necessitated this modification. The development and maintenance of Iowa's system is described. Evaluation is provided by analysis of commonly available birth and mortality data. Improved birth-weight-specific neonatal and fetal mortality rates suggest an overall improvement in care. A more favorable birth weight distribution and evidence of screening and selective referral of high-risk patients provide evidence of improvements in prenatal care. Data are presented to show that a stratified system of care is evidence in the state. Level I hospitals currently manage low-risk patients and report very low mortality rates. Level II facilities receive high-risk referrals, but selective referral occurs since the tertiary center accounts for a disproportionate number of fetal and neonatal deaths, and births weighting less than 1500 g. Other regions may benefit from similar approaches to development of regionalized systems of care and evaluation of the same.

Entities:  

Mesh:

Year:  1986        PMID: 3956827     DOI: 10.1016/0028-2243(86)90043-2

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  Mechanical ventilation in rural ICUs.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

2.  Towards a better understanding of risk selection in maternal and newborn care: A systematic scoping review.

Authors:  Bahareh Goodarzi; Annika Walker; Lianne Holten; Linda Schoonmade; Pim Teunissen; François Schellevis; Ank de Jonge
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.